# UChicago Medicine account plan

> UChicago Medicine is the University of Chicago's nonprofit academic health system, with FY2025 operating revenues of $5,239,341 thousand.

## At a glance

The University of Chicago Medical Center (UCMC), operating as UChicago Medicine, is the parent of an integrated nonprofit academic health system in Chicago, working with the University's Biological Sciences Division, the Pritzker School of Medicine and the University of Chicago Physicians Group. It runs the Hyde Park academic medical center (including Comer Children's Hospital), Ingalls Memorial Hospital and, through a joint venture with AdventHealth, hospitals in the Southwest and Western suburbs of Chicago. In the fiscal year ended June 30, 2025 total operating revenues were $5,239,341 thousand (FY2024: $4,625,173 thousand) and operating revenue in excess of expenses was $79,826 thousand. The University of Chicago is its sole corporate member and elects its Board of Trustees.

## Business units

- **The University of Chicago Medical Center (Hyde Park)** (about 67% of FY2025 operating revenues ($3,525,356 thousand, computed)): The academic medical center: the Center for Care and Discovery, Bernard Mitchell Hospital, Chicago Lying-In Hospital, Comer Children's Hospital and the Duchossois Center for Advanced Medicine. It generated operating revenue in excess of expenses of $158,273 thousand, the main source of System operating income, and holds most of the System's debt.
- **AdventHealth Great Lakes Region** (about 22% of FY2025 operating revenues ($1,140,525 thousand, computed)): A joint venture controlled by UCMC with AdventHealth as minority member, extending the system to the Southwest and Western suburbs of Chicago under the UChicago Medicine brand. It ran an operating deficit of $32,808 thousand in FY2025.
- **Ingalls Memorial Hospital** (about 8% of FY2025 operating revenues ($418,351 thousand, computed)): A member of the bond-issuing Obligated Group with patient service revenue of $403,706 thousand and operating revenue in excess of expenses of $31,471 thousand in FY2025.
- **Physician group and other non-obligated entities** (about 3% of FY2025 operating revenues ($176,611 thousand, computed)): UCM Medical Group, UCM Physician Partners, UCM ACO, UChicago Medicine Northwest Indiana, UCM Services Corp. and the captive insurer Trulen. Together they ran an operating deficit of $74,790 thousand in FY2025.

## Strategic priorities

- **Capital build-out**: Purchases of property, plant and equipment reached $407,843 thousand in FY2025 (FY2024: $259,188 thousand), with construction in progress of $477,734 thousand and about $370,237 thousand of committed capital projects at June 30, 2025.
- **Suburban expansion with AdventHealth**: The AdventHealth Great Lakes Region joint venture extends the integrated academic system to the Southwest and Western suburbs of Chicago.
- **Shift to outpatient care**: Outpatient and ambulatory care revenue of $2,116,471 thousand now exceeds inpatient revenue of $1,993,807 thousand in FY2025.
- **Renew the University affiliation**: The affiliation agreement's initial 40-year term ends October 1, 2026 and renews automatically for successive 10-year terms unless either party gives two years' notice.

## Investments and deals

- **New bond issues**: Series 2025A1 ($96,690 thousand), 2025A2 ($97,135 thousand) and 2025A3 ($96,260 thousand) bonds were issued at 5.0% under a Master Trust Indenture dated June 1, 2025, while older series were redeemed.
- **Facilities and equipment**: Purchases of property, plant and equipment of $407,843 thousand in FY2025; equipment at cost rose to $1,203,166 thousand from $1,050,200 thousand.
- **Community benefits**: Community benefits totalled $869,134 thousand in FY2025, including charity care of $49,148 thousand and unreimbursed education of $93,184 thousand.

## Challenges and risks

- **Thinner operating margin**: Operating revenue in excess of expenses fell to $79,826 thousand from $110,951 thousand as supplies and other costs rose to $2,061,796 thousand from $1,703,990 thousand.
- **Medicare and Medicaid dependence**: Medicare and Medicaid rules are complex and federal enforcement on billing and clinical documentation has increased; Medicaid reimbursement depends on Illinois Medicaid funding.
- **Loss-making entities**: AdventHealth Great Lakes Region and the physician group entities ran operating deficits of $32,808 thousand and $74,790 thousand in FY2025.
- **Variable-rate debt and giving**: Variable-rate debt is backed by letters of credit expiring between April 2026 and May 2029 with a 1.25:1 debt service coverage covenant, and the One Big Beautiful Bill Act may affect charitable giving.

## Where a supplier can help

- **Construction and medical equipment**: About $370,237 thousand of committed capital projects and rising equipment spending tie to the capital build-out priority.
- **Supply cost control**: Supplies and other costs grew to $2,061,796 thousand, squeezing the operating margin; procurement, supply chain and pharmacy cost tools address that challenge.
- **Billing and documentation compliance**: Increased federal enforcement on billing and clinical documentation points to revenue-cycle, coding and compliance solutions.
- **Outpatient and suburban care delivery**: The shift to outpatient care and the AdventHealth suburban joint venture fit ambulatory-care technology, scheduling and network-integration services.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [The University of Chicago Medical Center - Consolidated Financial Statements, June 30, 2025 and 2024 (audited)](https://edge.sitecorecloud.io/unichicagomc-81nbqnb3/media/pdfs/adult-pdfs/about-us/financial-information/2025-audited.pdf)

Annual report · 2025-11-21

- The University of Chicago Medical Center (UCMC, brand UChicago Medicine) is the parent of an integrated nonprofit academic health system in Chicago; the University of Chicago is its sole corporate member and elects its Board of Trustees. Fiscal year ends June 30.
- FY2025 total operating revenues were $5,239,341 thousand (FY2024: $4,625,173 thousand); patient service revenue $4,408,910 thousand and other operating revenue $830,431 thousand, with a substantial portion of the latter from the 340b contract pharmacy program.
- Margins thinned: operating revenue in excess of expenses fell to $79,826 thousand from $110,951 thousand as total operating expenses rose to $5,159,515 thousand; supplies and other grew to $2,061,796 thousand (from $1,703,990 thousand) and salaries, wages and benefits to $2,148,601 thousand.
- Four operating blocks by FY2025 operating revenue (shares computed from the consolidating schedule): the UCMC academic medical center (Hyde Park hospitals, Comer Children's) $3,525,356 thousand (about 67%); AdventHealth Great Lakes Region, a joint venture controlled by UCMC with AdventHealth as minority member, $1,140,525 thousand (about 22%, operating deficit of $32,808 thousand); Ingalls Memorial Hospital $418,351 thousand (about 8%); physician group and other non-obligated entities $176,611 thousand.
- Payor mix of patient service revenue: managed care $2,139,107 thousand, Medicare $1,342,485 thousand, Medicaid $896,649 thousand; Illinois's Hospital Assessment Program added a net $185,261 thousand to operating income.
- Heavy capital build: purchases of property, plant and equipment reached $407,843 thousand (FY2024: $259,188 thousand), construction in progress $477,734 thousand and contractual commitments on capital projects about $370,237 thousand at June 30, 2025.
- Balance sheet strengthened: cash $530,157 thousand (from $183,072 thousand), total assets $5,772,415 thousand, net assets $3,013,172 thousand; long-term debt of $1,377,981 thousand after new Series 2025A1-A3 bonds issued under a Master Trust Indenture dated June 1, 2025.
- UCMC pays the University's Division of Biological Sciences for physician services ($567,074 thousand in FY2025, up from $355,424 thousand) and transfers $71,750 thousand a year to the University for academic programs; the affiliation agreement's initial 40-year term ends October 1, 2026 and renews automatically for 10-year terms.
- Risks named: dependence on Medicare and Medicaid rules and Illinois Medicaid funding, increased federal enforcement on billing and documentation, the One Big Beautiful Bill Act's effect on charitable giving (under evaluation), variable-rate debt backed by letters of credit expiring 2026-2029 with a 1.25:1 debt service coverage covenant.

## Questions about UChicago Medicine

### What is UChicago Medicine?

The University of Chicago Medical Center, operating as UChicago Medicine, is the parent of an integrated nonprofit academic health system in Chicago, including the Hyde Park academic medical center, Ingalls Memorial Hospital and the AdventHealth Great Lakes Region joint venture.

### What is UChicago Medicine's revenue?

Total operating revenues were $5,239,341 thousand in the fiscal year ended June 30, 2025, up from $4,625,173 thousand, with patient service revenue of $4,408,910 thousand.

### Who controls UChicago Medicine?

The University of Chicago is the sole corporate member of UCMC, elects its Board of Trustees and approves its bylaws; all medical staff hold academic appointments at the University.

### What is UChicago Medicine investing in?

Facilities and equipment: purchases of property, plant and equipment were $407,843 thousand in FY2025, funded in part by new Series 2025 bonds.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
